Table 1.
ASO | Sequence (5′–3′) |
---|---|
ASO#26 | GATAAATGTACTCTGT |
ASO#27 | GCATATCAATTTCCTG |
ASO#136 | GTAACTTATATCTTGG |
Control-ASO | GGCCAATACGCCGTCA |
The sequences of the antisense oligonucleotides used for the in vivo experiments.
ASO | Sequence (5′–3′) |
---|---|
ASO#26 | GATAAATGTACTCTGT |
ASO#27 | GCATATCAATTTCCTG |
ASO#136 | GTAACTTATATCTTGG |
Control-ASO | GGCCAATACGCCGTCA |
The sequences of the antisense oligonucleotides used for the in vivo experiments.